Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Use of inhaled iloprost in children with pulmonary hypertension.

Moreno-Galdó A, Torrent-Vernetta A, de Mir Messa I, Rovira Amigo S, Gran Piña F, Gartner S, Albert Brotons D.

Pediatr Pulmonol. 2015 Apr;50(4):370-9. doi: 10.1002/ppul.23044. Epub 2014 Apr 11.

PMID:
24729548
2.

Long-term inhaled iloprost use in children with pulmonary arterial hypertension.

Alehan D, Yıldırım I, Sahin M, Ozkutlu S, Ozer S, Karagöz T.

Cardiol Young. 2012 Aug;22(4):396-403. doi: 10.1017/S1047951111001843. Epub 2011 Nov 9.

PMID:
22067137
3.

Iloprost for children with pulmonary hypertension after surgery to correct congenital heart disease.

Xu Z, Zhu L, Liu X, Gong X, Gattrell W, Liu J.

Pediatr Pulmonol. 2015 Jun;50(6):588-95. doi: 10.1002/ppul.23032. Epub 2014 Mar 9.

PMID:
24610631
4.

Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension.

Ivy DD, Doran AK, Smith KJ, Mallory GB Jr, Beghetti M, Barst RJ, Brady D, Law Y, Parker D, Claussen L, Abman SH.

J Am Coll Cardiol. 2008 Jan 15;51(2):161-9. doi: 10.1016/j.jacc.2007.09.031.

5.

Oral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the newborn.

Kahveci H, Yilmaz O, Avsar UZ, Ciftel M, Kilic O, Laloglu F, Ozturk K.

Pediatr Pulmonol. 2014 Dec;49(12):1205-13. doi: 10.1002/ppul.22985. Epub 2014 Jan 14.

PMID:
24420987
6.

Peri-operative pulmonary hypertension in paediatric patients: current strategies in children with congenital heart disease.

Gorenflo M, Gu H, Xu Z.

Cardiology. 2010;116(1):10-7. doi: 10.1159/000313864. Epub 2010 Apr 24.

PMID:
20424447
7.

[Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].

Olschewski H, Ghofrani HA, Walmrath D, Schermuly R, Temmesfeld-Wollbrück B, Grimminger F, Seeger W.

Pneumologie. 2000 Mar;54(3):133-42. German.

PMID:
10783653
8.

Intravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertension.

Hoeper MM, Spiekerkoetter E, Westerkamp V, Gatzke R, Fabel H.

Eur Respir J. 2002 Aug;20(2):339-43.

9.

Inhaled iloprost for the control of acute pulmonary hypertension in children: a systematic review.

Mulligan C, Beghetti M.

Pediatr Crit Care Med. 2012 Jul;13(4):472-80. doi: 10.1097/PCC.0b013e31822f192b. Review.

PMID:
21926655
10.

[Effect of nebulised iloprost combined with inhaled nitric oxide and oral sildenafil on lung transplant patients. Therapeutic efficacy in pulmonary hypertension during surgery].

Rabanal Llevot JM, Cimadevilla Calvo B, Cifrian Martinez JM, Ruisanchez Villar C, Mons Lera R.

Rev Esp Anestesiol Reanim. 2012 Mar;59(3):142-9. doi: 10.1016/j.redar.2012.04.002. Epub 2012 May 3. Spanish.

PMID:
22985755
11.

Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group.

Olschewski H, Ghofrani HA, Schmehl T, Winkler J, Wilkens H, Höper MM, Behr J, Kleber FX, Seeger W.

Ann Intern Med. 2000 Mar 21;132(6):435-43.

PMID:
10733442
12.

Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.

Olschewski H, Ghofrani HA, Walmrath D, Schermuly R, Temmesfeld-Wollbruck B, Grimminger F, Seeger W.

Am J Respir Crit Care Med. 1999 Aug;160(2):600-7.

PMID:
10430735
13.

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

Ghofrani HA, Wiedemann R, Rose F, Olschewski H, Schermuly RT, Weissmann N, Seeger W, Grimminger F.

Ann Intern Med. 2002 Apr 2;136(7):515-22.

PMID:
11926786
14.

Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension.

Ghofrani HA, Rose F, Schermuly RT, Olschewski H, Wiedemann R, Kreckel A, Weissmann N, Ghofrani S, Enke B, Seeger W, Grimminger F.

J Am Coll Cardiol. 2003 Jul 2;42(1):158-64.

15.

Inhaled iloprost controls pulmonary hypertension after cardiopulmonary bypass.

Theodoraki K, Rellia P, Thanopoulos A, Tsourelis L, Zarkalis D, Sfyrakis P, Antoniou T.

Can J Anaesth. 2002 Nov;49(9):963-7.

PMID:
12419726
16.

Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery.

Antoniou T, Koletsis EN, Prokakis C, Rellia P, Thanopoulos A, Theodoraki K, Zarkalis D, Sfyrakis P.

J Cardiothorac Vasc Anesth. 2013 Jun;27(3):459-66. doi: 10.1053/j.jvca.2012.07.020. Epub 2012 Oct 10.

PMID:
23063102
17.

Review of inhaled iloprost for the control of pulmonary artery hypertension in children.

Tissot C, Beghetti M.

Vasc Health Risk Manag. 2009;5(1):325-31. Epub 2009 Apr 8. Review.

18.

Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension.

Wilkens H, Guth A, König J, Forestier N, Cremers B, Hennen B, Böhm M, Sybrecht GW.

Circulation. 2001 Sep 11;104(11):1218-22.

19.

Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.

Opitz CF, Wensel R, Bettmann M, Schaffarczyk R, Linscheid M, Hetzer R, Ewert R.

Eur Heart J. 2003 Feb;24(4):356-65.

20.

Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy.

Knudsen L, Schurawlew A, Nickel N, Tiede H, Ghofrani HA, Wilkens H, Ewert R, Halank M, Klose H, Bäzner C, Behr J, Hoeper MM.

BMC Pulm Med. 2011 Dec 1;11:56. doi: 10.1186/1471-2466-11-56.

Items per page

Supplemental Content

Write to the Help Desk